NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.
复制标题
DOI:
10.1016/j.bbmt.2020.09.030
复制
发表时间:
2021-01
影响因子:
3.2
通讯作者:
Cruz CRY
中科院分区:
文献类型:
--
作者:
Sanchez CE;Dowlati EP;Geiger AE;Chaudhry K;Tovar MA;Bollard CM;Cruz CRY
Natural killer (NK) cells, the primary effector cells of the innate immune system, utilize multiple strategies to recognize tumor cells by (1) detecting the presence of activating receptor ligands, which are often upregulated in cancer; (2) targeting cells that have a loss of major histocompatibility complex (MHC); and (3) binding to antibodies that bind to tumor-specific antigens on the tumor cell surface. All these strategies have been successfully harnessed in adoptive NK cell immunotherapies targeting cancer. In this review, we review the applications of NK cell therapies across different tumor types. Similar to other forms of immunotherapy, tumor-induced immune escape and immune suppression can limit NK cell therapies’ efficacy. Therefore, we also discuss how these limitations can be overcome by conferring NK cells with the ability to redirect their tumor-targeting capabilities and survive the immune-suppressive tumor microenvironment. Finally, we also discuss how future iterations can benefit from combination therapies with other immunotherapeutic agents.
登录
查看更多内容
影响因子:
20.3
作者:
Bollard, CM;Rössig, C;Rooney, CM
通讯作者:
Rooney, CM
影响因子:
56.9
作者:
Bauer, S;Groh, V;Spies, T
通讯作者:
Spies, T
影响因子:
4.4
作者:
Campbell, JJ;Qin, SX;Butcher, EC
通讯作者:
Butcher, EC
影响因子:
5.6
作者:
Beldi-Ferchiou A;Caillat-Zucman S
通讯作者:
Caillat-Zucman S
影响因子:
50.5
作者:
Bang, Y. J.;Giaccone, G.;Burris, H. A.
通讯作者:
Burris, H. A.